Rimah Sharief
Pediatrics · Staten Island, NYNPI 1467891283
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $738 and has fallen 82.1% since, to $132 in 2025. Among pediatrics clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $22.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arbor Pharmaceuticals, Inc.$453
- Sanofi-aventis U.S. LLC$358
- Ascendis Pharma Endocrinology Inc$223
- Medtronic$220
- Azurity Pharmaceuticals, Inc.$192
- Rhythm Pharmaceuticals, Inc.$132
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,82498%
- Education$652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arbor Pharmaceuticals, Inc. | 23 | $453 |
| Sanofi-aventis U.S. LLC | 6 | $358 |
| Ascendis Pharma Endocrinology Inc | 9 | $223 |
| Medtronic(2 entities) | 5 | $220 |
| Azurity Pharmaceuticals, Inc. | 10 | $192 |
| Rhythm Pharmaceuticals, Inc. | 6 | $132 |
| Tolmar, Inc. | 7 | $129 |
| Dexcom, Inc. | 7 | $123 |
| Xeris Pharmaceuticals, Inc. | 6 | $107 |
| Endo Pharmaceuticals Inc. | 5 | $98 |
| Insulet Corporation | 5 | $87 |
| Novo Nordisk | 3 | $86 |
| Abbott | 4 | $85 |
| Amphastar Pharmaceuticals, Inc. | 5 | $83 |
| Tolmar Pharmaceuticals, Inc. | 4 | $78 |
| AstraZeneca | 4 | $75 |
| AbbVie | 3 | $62 |
| Tandem Diabetes Care, Inc. | 3 | $54 |
| Ipsen Biopharmaceuticals, Inc | 2 | $46 |
| Pfizer | 2 | $38 |
| Neurocrine Biosciences, Inc. | 1 | $30 |
| Beckman Coulter, Inc. | 1 | $29 |
| Lilly USA, LLC | 2 | $28 |
| Zealand Pharma US, Inc. | 1 | $21 |
| Intuity Medical Inc | 1 | $20 |
| Eton Pharmaceuticals, Inc. | 1 | $20 |
| Companion Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$249
- Minimed 530G$134
How this compares
$2,889 in reported general payments places this provider in the 95th percentile of 4,055 pediatrics providers in New York.
Other pediatrics in Staten Island
- Philip OzuahBronx$1M
- Michael PichicheroRochester$168K
- Patrick SchnellBrooklyn$164K
- Warren SeigelBrooklyn$162K
- Rachael PhelpsRochester$156K
- Sarita GeorgeMineola$90K
- Kathryn FitzgeraldNew York$80K
- Rudolph LeibelNew York$67K
- Shakeel ModakNew York$64K
- Jean-Laurent CasanovaNew York$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.